Basaglar is a prescription drug approved by the Food and Drug Administration (FDA) to treat type 2 diabetes in adults and both adults and children with type 1 diabetes. Basaglar is also referred to by its drug name, Insulin glargine. Your doctor may prescribe another type of insulin or an oral medication such as Metformin to take along with Basaglar.
Basaglar is a long-acting insulin and a human insulin analog. An insulin analog is a synthetic substance very similar to human insulin. Insulin analogs are designed to affect the body more predictably than human insulin does.
How do I take it?
Prescribing information states that Basaglar should be administered via a subcutaneous injection. Your doctor will explain when and where you should inject Basaglar and how to measure your dosage. Basaglar is injected once daily at the same time each day.
Basaglar comes as a prefilled pen.
The FDA-approved label for Basaglar lists common side effects including upper respiratory tract infections and minor redness or irritation at injection sites.
Rare but serious side effects listed for Basaglar can include a systemic allergic reaction.